Correction to: Hepatitis C virus core protein activates Wnt/β-catenin signaling through multiple regulation of upstream molecules in the SMMC-7721 cell line (Archives of Virology, (2011), 156, 6, (1013-1023), 10.1007/s00705-011-0943-x);Hepatitis C virus core protein activates Wnt/β-catenin signaling through multiple regulation of upstream molecules in the SMMC-7721 cell line

Archives of Virology

Volumn 156, Issue 6, 2011, Pages 1013-1023

  Liu, Jiao ^a   Wang, Zengchan ^a   Tang, Jia ^a   Tang, Renkuan ^a   Shan, Xiaoliang ^a   Zhang, Wenlu ^a   Chen, Qingmei ^a   Zhou, Fan ^a   Chen, Ke ^a   Huang, Ailong ^a   Tang, Ni ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C VIRUS;

EID: 79957945839     PISSN: 03048608     EISSN: 14328798     Source Type: Journal    
DOI: 10.1007/s00705-021-05275-9     Document Type: Erratum

References (51)

1. Alter HJ (1995) To C or not to C: these are the questions. Blood 85: 1681-1695.
2. WHO (1997) Hepatitis C: global prevalence. Wkly Epidemiol Rec 72: 341-348.
3. Georgel P, Schuster C, Zeisel MB, Stoll-Keller F, Berg T, Bahram S, Baumert TF (2010) Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies. Trends Mol Med 16(6): 277-286.
4. Drazan KE (2000) Molecular biology of hepatitis-C infection. Liver Transpl 6: 396-406.
5. Kang SM, Choi JK, Kim SJ, Kim JH, Ahn DG, Oh JW (2009) Regulation of hepatitis C virus replication by the core protein through its interaction with viral RNA polymerase. Biochem Biophys Res Commun 386: 55-59.
6. Masaki T, Suzuki R, Murakami K, Aizaki H, Ishii K, Murayama A, Date T, Matsuura Y, Miyamura T, Wakita T, Suzuki T (2008) Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J Virol 82: 7964-7976.
7. Majeau N, Fromentin R, Savard C, Duval M, Tremblay MJ, Leclerc D (2009) Palmitoylation of hepatitis C virus core protein is important for virion production. J Biol Chem 284(49): 33915-33925.
8. Joo M, Hahn YS, Kwon M, Sadikot RT, Blackwell TS, Christman JW (2005) Hepatitis C virus core protein suppresses NF-kappaB activation and cyclooxygenase-2 expression by direct interaction with IkappaB kinase beta. J Virol 79(12): 7648-7657.
9. Cho J, Baek W, Yang S, Chang J, Sung YC, Suh M (2001) HCV core protein modulates Rb pathway through pRb down-regulation and E2F-1 up-regulation. Biochim Biophys Acta 1538(1): 59-66.
10. Kao CF, Chen SY, Chen JY, Wu Lee YH (2004) Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein. Oncogene 23(14): 2472-2483.
11. Battaglia S, Benzoubir N, Nobilet S, Charneau P, Samuel D, Zignego AL, Atfi A, Bre′chot C, Bourgeade MF (2009) Liver cancer-derived hepatitis C virus core proteins shift TGF-Beta responses from tumor suppression to epithelial-mesenchymal transition. PLoS One 4: e4355.
12. Ariumi Y, Kuroki M, Abe K, Dansako H, Ikeda M, Wakita T, Kato N (2007) DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication. J Virol 81(24): 13922-13926.
13. Yoshida T, Hanada T, Tokuhisa T, Kosai K, Sata M, Kohara M, Yoshimura A (2002) Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J Exp Med 196: 641-654.
14. Banerjee S, Saito K, Goughoulte MA, Meyer K, Ray RB, Rayet R (2008) Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream Akt/protein kinase b signaling pathway for insulin resistance. J Virol 82: 2606-2612.
15. Yuzugullu H, Benhaj K, Ozturk N, Senturk S, Celik E, Toylu A, Tasdemir N, Yilmaz M, Erdal E, Akcali KC, Atabey N, Ozturket M (2009) Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. Mol Cancer 8: 90.
16. Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
17. Herbst A, Kolligs FT (2007) Wnt signaling as a therapeutic target for cancer. Methods Mol Biol 361: 63-91.
18. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW (1998) Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
19. Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398(6726): 422-426.
20. Zhang T, Otevrel T, Gao Z, Gao Z, Ehrlich SM, Fields JZ, Boman BM (2001) Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 61(24): 8664-8667.
21. Bi Y, Huang JY, He Y, Zhu GH, Su YX, He BC, Luo JY, Wang Y, Kang Q, Luo Q, Chen L, Zuo GW, Jiang W, Liu B, Shi Q, Tang M, Zhang BQ, Weng YG, Huang AL, Zhou L, Feng T, Luu HH, Haydon RC, He TC, Tang N (2009) Wnt Antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells. J Cell Biochem 108: 295-303.
22. de la Coste A, Romagnol B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C (1998) Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95: 8847-8851.
23. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujitam M, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y (2000) AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Gen 24: 245-250.
24. Oda H, Imai Y, Nakatsuru Y, Hata J, Ishikawa T (1996) Somatic mutations of the APC gene in sporadic hepatoblastomas. Cancer Res 56: 3320-3323.
25. Ban KC, Singh H, Krishnan R, Seow HF (2003) GSK-3β phosphorylation and alteration of β-catenin in hepatocellular carcinoma. Cancer Lett 199: 201-208.
26. Miyoshi Y, Iwao K, Nagasawa Y, Aihara T, Sasaki Y, Imaoka S, Murata M, Shimano T, Nakamura Y (1998) Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res 58: 2524-2527.
27. Merle P, de la Monte S, Kim M, Herrmann M, Tanaka S, Von Dem Bussche A, Kem MC, Trepo C, Wands JR (2004) Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma. Gastroenterology 127: 1110-1122.
28. Fukutomi T, Zhou Y, Kawai S, Eguchi H, Wands JR, Li J (2005) Hepatitis C virus core protein stimulates hepatocyte growth: correlation with upregulation of Wnt1 expression. Hepatology 41: 1096-1105.
29. Hu YW, Liu CY, Du CM, Zhang J, Wu WQ, Gu ZL (2009) Induction of apoptosis in human hepatocarcinoma SMMC-7721 cells in vitro by flavonoids from Astragalus complanatus. J Ethnopharmacol 123(2): 293-301.
30. Li S, Dong P, Wang J, Zhang J, Gu J, Wu X, Wu W, Fei X, Zhang Z, Wang Y, Quan Z, Liu Y (2010) Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC-7721 cells via a ROS/JNK-dependent mitochondrial pathway. Cancer Lett 298(2): 222-230.
31. Luo JY, Deng ZL, Luo XJ, Tang N, Song WX, Chen J, Sharff AK, Luu HH, Haydon RC, Kinzler WK, Vogelstein B, He TC (2007) A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2(5): 1236-1247.
32. Si W, Kang Q, Luu HH, Park JK, Luo Q, Song WX, Jiang W, Luo X, Li X, Yin H, Montag AG, Haydon RC, He TC (2006) CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol 26(8): 2955-2964.
33. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95(5): 2509-2514.
34. Tang N, Song WX, Luo J, Luo X, Chen J, Sharff KA, Bi Y, He BC, Huang JY, Zhu GH, Su YX, Jiang W, Tang M, He Y, Wang Y, Chen L, Zuo GW, Shen J, Pan X, Reid RR, Luu HH, Haydon RC, He TC (2009) BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling. J Cell Mol Med 13(8B): 2448-2464.
35. Castro-Garza J, Barrios-García HB, Cruz-Vega DE, Said-Fernández S, Carranza-Rosales P, Molina-Torres CA, Vera-Cabrera L (2007) Use of a colorimetric assay to measure differences in cytotoxicity of Mycobacterium tuberculosis strains. J Med Microbiol 56(Pt 6): 733-737.
36. Longo KA, Kennell JA, Ochocinska MJ, Ross SE, Wright WS, MacDougald OA (2002) Wnt signaling protects 3T3-L1 preadipocytes from apoptosis through induction of insulin-like growth factors. J Biol Chem 277(41): 38239-38244.
37. Hou XN, Tan Y, Li ML, Dey SK, Das SK (2004) Canonical Wnt signaling is critical to estrogen-mediated uterine growth. Mol Endocrinol 18(12): 3035-3049.
38. Chen L, Wang K, Shao Y, Huang J, Li X, Shan J, Wu D, Zheng JJ (2008) Structural insight into the mechanisms of Wnt signaling antagonism by Dkk. J Biol Chem 283(34): 23364-23370.
39. Montgomery E, Torbenson MS, Kaushal M, Fisher C, Abraham SC (2002) Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol 26(10): 1296-1301.
40. Sakamoto A, Oda Y, Adachi T, Saito T, Tamiya S, Iwamoto Y, Tsuneyoshi M (2002) Beta-catenin accumulation and gene mutation in exon 3 in dedifferentiated liposarcoma and malignant fibrous histiocytoma. Arch Pathol Lab Med 126(9): 1071-1078.
41. Haydon RC, Deyrup A, Ishikawa A, Heck R, Jiang W, Zhou L, Feng T, King D, Cheng H, Breyer B, Peabody T, Simon MA, Montag AG, He TC (2002) Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma. Int J Cancer 102(4): 338-342.
42. MacDonald BT, Tamai K, He X (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9-26.
43. Mukai A, Yamamoto-Hino M, Awano W, Watanabe W, Komada M, Goto S (2010) Balanced ubiquitylation and deubiquitylation of Frizzled regulate cellular responsiveness to Wg/Wnt. EMBO J 29: 2114-2125.
44. Monga SPS (2009) Role of Wnt/β-catenin signaling in liver metabolism and cancer. Int J Biochem Cell Biol 3084-3093.
45. Li YH, Lu WY, King TD, Liu CC, Bijur GN, Bu GJ (2010) Dkk1 stabilizes Wnt co-receptor LRP6: implication for Wnt ligand-induced LRP6 down-regulation. PLoS One e11014.
46. Ugolini F, Adélaïde J, Charafe-Jauffret E, Ngugen C, Jacquemier J, Jordan B, Birnbaun D, Pebusque MJ (1999) Differential expression assay of chromosome arm 8p genes identifies frizzled-related (FRP1/FRZB) and fibroblast Growth factor receptor 1 (FGFR1) as candidate breast cancer genes. Oncogene 18: 1903-1910.
47. Nagahata T, Shimada T, Harada A, Naga H, Onda M, Yokoyama S, Shiba T, Jin E, Kawanami O, Emi M (2003) Amplification, up-regulation and over-expression of DVL-1, the human counterpart of the Drosophila disheveled gene, in primary breast cancers. Cancer Sci 94: 515-518.
48. Merle P, Kim M, Herrmann M, Gupte A, Lefrançois L, Califano S, Trépo C, Tanaka S, Vitvitski L, de la Monte S, Wands JR (2005) Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma. J Hepatol 43(5): 854-862.
49. Terris B, Pineau P, Bregeaud L, Valla D, Belghiti J, Tiollais P, Degott C, Dejean A (1999) Close correlation between beta-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas. Oncogene 18(47): 6583-6588.
50. Yamanaka T, Kodama T, Doi T (2002) Subcellular localization of HCV core protein regulates its ability for p53 activation and p21 suppression. Biochem Biophys Res Commun 294: 528-534.
51. Zakut R, Givol D (1995) The tumor suppression function of p21Waf is contained in its N-terminal half ('half-WAF'). Oncogene 11: 393-395.